If Two Heads Are Better Than One….

…..then the combined minds of the National Institutes of Health, ten major drug companies, and seven nonprofit groups ought to be able to make some progress.  This unique collaboration plans to target treatment development for lupus, rheumatoid arthritis, Alzheimer’s, and Type 2 diabetes over the next 5 years.  The group were compelled to cooperation for different reasons: major drug companies have invested and lost in many promising treatments while other groups are inundated in biological data.  Hopefully, by their powers combined, effective treatment option for these debilitating diseases.


(NIH Clinical Research Center from Wikicommons)

Read more about why these disorders were selected, the reasons for the joint effort, and more at the New York Times:


Click to comment

Leave a Comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Good News That's Real News

Sign-Up For The Latest From TGNR

Never miss when good news that's real news drops. Sign-up now to enjoy TGNR from your inbox!


TGNR is the registered and trademarked property of Kizer-Mitsui Publishing House, LLC. TGNR content is the exclusive property of Kizer-Mitsui, Copyright © 2018.

To Top